Medicine and Dentistry
Hemostat
100%
Liver Cirrhosis
83%
Liver Transplantation
74%
Liver Disease
70%
Bleeding
58%
Blood Stasis
58%
Machine Perfusion
56%
Platelet
50%
Thrombin
47%
Von Willebrand Factor
39%
Thrombosis
38%
Antithrombotic
25%
Fibrinolysis
24%
Acute Liver Failure
22%
Anticoagulation
19%
Partial Hepatectomy
19%
Fibrinogen
18%
Ex Vivo
18%
Euglobulin Lysis Test
18%
Von Willebrand Factor Cleaving Proteinase
17%
Portal Vein Thrombosis
17%
Liver Graft
17%
Liver Injury
17%
Chronic Liver Disease
16%
Heparin
15%
In Vitro
14%
Acute on Chronic Liver Failure
13%
Disease
13%
Coagulopathy
12%
Liver Regeneration
12%
COVID-19
12%
Hypercoagulability
12%
Bile Duct
11%
Blood Clotting Factor
11%
Injury
11%
Procoagulant
11%
Venous Thromboembolism
11%
Bile Duct Injury
11%
Thromboplastin
11%
Kidney Transplantation
11%
Thrombomodulin
10%
Recombinant Blood Clotting Factor 7a
10%
Blood Clotting
10%
Pediatrics
10%
Thromboembolism
10%
Thrombocyte Function
9%
Cholestasis
9%
Thrombocyte Activation
9%
Fibrin Clot
9%
Thromboprophylaxis
9%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cirrhosis
45%
Thrombin
37%
Von Willebrand Factor
27%
Anticoagulant Agent
27%
Hemostatic Agent
25%
Bleeding
23%
Blood Stasis
22%
Liver Disease
20%
Fibrinolytic Agent
18%
Thrombosis
17%
Mouse
17%
Disease
12%
Acute on Chronic Liver Failure
11%
Thromboplastin
11%
Chronic Liver Disease
11%
Hypercoagulability
10%
Prothrombin
10%
Inflammation
10%
Recombinant Blood Clotting Factor 7a
10%
Heparin
9%
Von Willebrand Factor Cleaving Proteinase
9%
Acute Liver Failure
9%
Coronavirinae
9%
Vein Thrombosis
9%
Heart Infarction
8%
Thrombin Activatable Fibrinolysis Inhibitor
8%
Thrombomodulin
8%
D Dimer
8%
Portal Hypertension
8%
Procoagulant
7%
Decompensated Liver Cirrhosis
7%
Blood Clotting Factor
7%
Tissue Plasminogen Activator
6%
Reperfusion Injury
6%
Liver Injury
6%
Prothrombin Complex
6%
End Stage Liver Disease
6%
Leg Injury
6%
Direct Oral Anticoagulant
6%
Venous Thromboembolism
6%
Fibrinogen
5%
Plasminogen
5%
Blood Clotting Factor 8
5%
Artery Thrombosis
5%
Thrombocytopenia
5%
Plasminogen Activator Inhibitor 1
5%
Clinical Trial
5%
Blood Clotting Disorder
5%
Blood Clotting Factor 13
5%
Thromboembolism
5%
Keyphrases
Cirrhosis
28%
Von Willebrand Factor
20%
Liver Disease
19%
Hemostasis
18%
Liver Transplantation
16%
Transplantation
15%
Donor Liver
15%
Patients with Liver Disease
14%
Thrombosis
14%
Bleeding
14%
Platelets
13%
Liver
13%
Acute Liver Failure
13%
Hemostatic System
11%
Anticoagulants
10%
Thrombin Generation
9%
Plasma Parameters
9%
Bleeding Complications
8%
Clot Lysis
8%
Hypofibrinolysis
8%
Hypothermic Machine Perfusion
8%
Hypothermic Oxygenated Machine Perfusion
8%
Normothermic Machine Perfusion
8%
Coagulation
8%
Hypercoagulability
8%
Fibrinolysis
7%
Haemostatic Proteins
7%
Thrombocytopenia
7%
Platelet Count
7%
Antihemostatic
6%
Fibrinolytic Proteins
6%
Anticoagulation
6%
Human Donor
6%
ADAMTS13
6%
Neutrophil Extracellular Traps
6%
Prospective Cohort Study
6%
End-stage Liver Disease
6%
Portal Hypertension
6%
Prothrombin Complex Concentrate
6%
Thrombotic Complications
5%
Heparin
5%
Risk Factors
5%
Orthotopic Liver Transplantation
5%
Thromboprophylaxis
5%
Portal Vein Thrombosis
5%
Bile
5%
Clinical Outcomes
5%
Circulatory Death
5%
Bleeding Risk
5%
Thrombolytic Potential
5%
